Bayer Ag Stock Performance
| BAYZF Stock | USD 24.09 0.13 0.54% |
On a scale of 0 to 100, Bayer AG holds a performance score of 13. The firm shows a Beta (market volatility) of 0.35, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bayer AG's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bayer AG is expected to be smaller as well. Please check Bayer AG's downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to make a quick decision on whether Bayer AG's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Bayer AG are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, Bayer AG reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 4.2 B | |
| Total Cashflows From Investing Activities | 855 M |
Bayer |
Bayer AG Relative Risk vs. Return Landscape
If you would invest 2,044 in Bayer AG on November 29, 2024 and sell it today you would earn a total of 365.00 from holding Bayer AG or generate 17.86% return on investment over 90 days. Bayer AG is currently producing 0.2935% returns and takes up 1.7351% volatility of returns over 90 trading days. Put another way, 15% of traded pink sheets are less volatile than Bayer, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Bayer AG Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bayer AG's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Bayer AG, and traders can use it to determine the average amount a Bayer AG's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1692
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BAYZF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.74 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.29 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Bayer AG is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bayer AG by adding it to a well-diversified portfolio.
Bayer AG Fundamentals Growth
Bayer Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Bayer AG, and Bayer AG fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bayer Pink Sheet performance.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0576 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 87.41 B | |||
| Shares Outstanding | 982.42 M | |||
| Price To Earning | 321.83 X | |||
| Price To Book | 1.36 X | |||
| Price To Sales | 1.06 X | |||
| Revenue | 44.08 B | |||
| EBITDA | 6.45 B | |||
| Cash And Equivalents | 8.19 B | |||
| Cash Per Share | 8.34 X | |||
| Total Debt | 35.55 B | |||
| Debt To Equity | 1.17 % | |||
| Book Value Per Share | 42.01 X | |||
| Cash Flow From Operations | 5.09 B | |||
| Earnings Per Share | 5.13 X | |||
| Total Asset | 120.24 B | |||
| Current Asset | 25.17 B | |||
| Current Liabilities | 16.68 B | |||
About Bayer AG Performance
By analyzing Bayer AG's fundamental ratios, stakeholders can gain valuable insights into Bayer AG's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bayer AG has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bayer AG has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Ag is traded on OTC Exchange in the United States.Things to note about Bayer AG performance evaluation
Checking the ongoing alerts about Bayer AG for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Bayer AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Bayer AG's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bayer AG's pink sheet performance include:- Analyzing Bayer AG's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bayer AG's stock is overvalued or undervalued compared to its peers.
- Examining Bayer AG's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bayer AG's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bayer AG's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bayer AG's pink sheet. These opinions can provide insight into Bayer AG's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bayer Pink Sheet analysis
When running Bayer AG's price analysis, check to measure Bayer AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer AG is operating at the current time. Most of Bayer AG's value examination focuses on studying past and present price action to predict the probability of Bayer AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer AG's price. Additionally, you may evaluate how the addition of Bayer AG to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |